In prostate cancer (PCa), curcumin interacts with multiple molecular targets, such as mTOR, p53, Ras, PI3K/Akt, and Wnt-β catenin, disrupting cancer growth at various stages. This evidence concerns the gene MTOR and posterior cortical atrophy.